Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
20.8%
% of OZEM's 25 holdings also in MEDX
16.7%
% of MEDX's 30 holdings also in OZEM
Overlap by Weight
Sector Drift (OZEM minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM | Weight in MEDX | Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 17.2% | 16.5% | 16.5% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.2% | 5.7% | 5.2% |
|
AMGEN INC | 4.9% | 6.6% | 4.9% |
|
PFIZER INC | 3.6% | 4.0% | 3.6% |
|
REGENERON PHARMACEUTICALS | 2.4% | 2.8% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
OZEM Overweight Relative to MEDX
 |
NOVO-NORDISK A/S-SPONS ADR | 12.4% |
 |
ROCHE HOLDING LTD | 6.3% |
 |
INNOVENT BIOLOGICS, INC. | 5.8% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 5.0% |
|
ZEALAND PHARMA A/S | 3.3% |
 |
HANMI PHARM CO LTD | 3.1% |
 |
THE UNITED LABORATORIES INTE | 3.0% |
|
GILEAD SCIENCES INC | 2.8% |
|
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 2.5% |
|
SHIONOGI & CO LTD | 2.3% |
OZEM Underweight Relative to MEDX
|
ABBVIE INC | -9.6% |
|
NOVARTIS AG-ADR | -6.8% |
|
BRISTOL-MYERS SQUIBB CO | -6.6% |
|
JOHNSON & JOHNSON | -5.2% |
 |
ALKERMES PLC | -4.6% |
|
ALNYLAM PHARMACEUTICALS INC | -4.5% |
|
MERCK & CO. INC. | -3.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.7% |
|
BIOGEN IDEC INC | -2.6% |
|
CRISPR THERAPEUTICS AG | -2.3% |